Fully Integrated Proton Therapy Software Platform adaPT Treatment Suite Goes Clinical

Cancer patients at Penn Medicine now benefit from the most advanced proton therapy software.

Philadelphia, United States, July 3, 2014 – Penn Medicine's Department of Radiation Oncology, the Roberts Proton Therapy Center and IBA (Ion Beam Applications SA) announce that the integrated proton therapy software suite, adaPT Treatment Suite, is now available for clinical use at Penn Medicine.

Penn Medicine has been fully upgraded with the most advanced proton therapy software suite, adaPT Treatment Suite, composed of adaPT Deliver and adaPT Insight*. This modular software platform provides a truly integrated treatment environment for the fastest, safest and most user-friendly proton therapy delivery.

adaPT Deliver

adaPT Deliver is the fully renovated front-end of the treatment delivery. It offers streamlined control of the patient treatment, along with full integration of the Treatment Planning System (TPS) and Oncology Information System (OIS) through DICOM connectivity.

adaPT Deliver provides Penn Medicine among all the other innovative features, the fastest Pencil Beam Scanning, the fastest Room Switching Time and Automatic Beam Operation.

adaPT Insight

adaPT Insight is the IBA imaging platform, which has been developed in collaboration with the University of Louvain-la-Neuve (UCL). It incorporates image-guidance features such as 3D CBCT** and stereoscopic X-Ray imaging for highly accurate patient treatment, as well as tight integration with adaPT Deliver. An open architecture and programmable workflow configurability builds a solid foundation for the development of future proton specific image-guided solutions.

adaPT Insight is now clinical at Penn Medicine for stereoscopic X-Ray imaging. 3D CBCT is under validation and the first expected clinical use will be in the 2nd half of 2014.

Dr. Alexander Lin, Director of Clinical Operations at Roberts Proton Therapy Center commented: “With adaPT Deliver, our PBS “beam on” time is reduced by 50% and the ultra-fast room switching time ensures that the beam could be shared with no waiting time in our 5-room facility. adaPT Insight provides image registration twice as quickly as our previous platform. The end results significantly benefit the patients, with improved efficiency and throughput, and enhanced accuracy of the proton therapy delivery. We believe that this is another step in improving our ability to helping patients achieve their goals of beating their cancer, and doing so in a way with as few side effects as possible.“

Olivier Legrain, IBA CEO added: “We are delighted to see that adaPT Treatment Suite allows more patients to benefit from Proton Therapy with both faster beam delivery and more accurate patient alignment. At IBA, we are committed to continue to provide the most advanced technologies to our partners and maintain our unrivalled position as an innovator and the world’s leader in the delivery of proton therapy. The fully integrated adaPT Deliver and adaPT Insight platforms constitute major milestones towards our vision of adaptive proton therapy.”

Beth Klein, VP Sales North America for IBA Proton Therapy, shared: “On top of the new centers equipped directly with adaPT Treatment Suite, we have scheduled to deploy it on more than 10 sites of our installed base in the coming two years to leverage the benefit to the patients worldwide and to further enhance the therapist's experience with efficient Proton Therapy delivery.”

* adaPT Insight is the first FDA cleared CBCT software solution in Proton Therapy. adaPT Insight is the brand name of the I2C software suite applicable to the IBA Proton Therapy solutions. (I2C:
FDA 510(k) K132847).

**CBCT is under development. The marketing approval will be subject to review by competent authorities (FDA, Notified bodies, et al…).